Physician profile
Gordon Mclennan
NPI 1922041946
$67,762.76
in general payments reported to CMS, 2019-2025
25 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $3,198 · 2021: $2,152 · 2022: $8,123 · 2023: $1,905 · 2024: $19K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $3,153 · Travel and Lodging: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,100.00 |
| Food and Beverage | $3,153.38 |
| Travel and Lodging | $821.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $40,759.34 | 2019-2025 | Venovo |
| Ge Healthcare | $14,648.42 | 2019-2022 | |
| Guerbet LLC | $2,929.37 | 2019-2024 | Lipiodol |
| Inari Medical, INC. | $2,916.79 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $2,044.44 | 2019-2023 | Angiodynamics |
| Instylla, INC. | $1,812.33 | 2021-2022 | |
| Medtronic, INC. | $548.08 | 2022-2024 | Osteocool Rf Ablation System, In.Pact Av, Abre |
| Trisalus Life Sciences, INC. | $502.36 | 2019-2022 | |
| Terumo Medical Corporation | $434.57 | 2019-2025 | Azur Cx Detachable, Angio-Seal, Progreat |
| Argon Medical Devices, INC. | $297.32 | 2019-2023 | Cleaner |
| Boston Scientific Corporation | $256.73 | 2019-2024 | |
| Asahi Intecc USA, INC. | $104.72 | 2025 | Asahi Interventional Radiology Wires, Asahi Peripheral Vascular Wires |
| Philips North America LLC | $100.44 | 2021 | |
| Biocompatibles, INC. | $92.51 | 2019 | |
| Progenics Pharmaceuticals, INC. | $62.08 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $57.34 | 2019 | |
| Sumitomo Pharma America, INC. | $51.36 | 2024-2025 | Orgovyx |
| Mediview Xr, INC. | $27.77 | 2022 | |
| Abbott Laboratories | $24.42 | 2020 | |
| Biosense Webster, INC. | $22.99 | 2021 | |
| Shockwave Medical, INC | $20.51 | 2021 | |
| Avanos Medical | $18.91 | 2019 | |
| Z-Medica, LLC | $18.45 | 2019 | |
| Covidien LP | $11.51 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Mclennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.